New Jersey dangles tax savings in front of Teva in bid to bag US HQ as revamp costs 200-plus jobs
In turmoil lies opportunity. And that may play out well for the New Jersey biopharma industry.
The state economic development group has laid out $40 million in tax savings to tempt Teva into moving its US headquarters to a 345,000-square-foot space space at 400 Interpace Parkway in Parsippany.
According to a report in NJBIZ, the state is looking for Teva to bring in 843 jobs, adding them to the more than 200 already in place in Parsippany.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
